Is BAX a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

2,532 people get BAX articles and Market Currents by email alert.

Get email alerts on BAX »

HEADLINES:

Baxter to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference

Business Wire (Mon, 9:00AM)
Cramer's Mad Money - 17 Things To Watch In The Week Ahead (5/17/13)
SA Editor Miriam Metzinger • Mon, May 20
Diversify Into Singapore Dollars And Get 4% Yields With High Quality Baa3 Rated Bonds
Randy Durig • Fri, May 17 • 4 Comments
Ultimate Sustainable Dividend Portfolio - May 2013 Update - Crushing the S&P 500
Intelligent Speculator • Wed, May 15 • 16 Comments
Does Cell Therapy Hold The Key To Treating Stroke?
PropThink • Mon, May 13 • 11 Comments
My K.I.S.S. Portfolio May 2013 Update
The Part-time Investor • Mon, May 13 • 60 Comments
Health Statistics Pioneer Dorothy P. Rice, Sc.D., Named 2013 Recipient of the William B. Graham Prize for Health Services Research

Business Wire (May 9, 2013)
Interviewing Dr. Losordo: The Promising Development Of CD34 Cells
Brian Nichols • Wed, May 8 • 13 Comments
Baxter International's CEO Hosts 2013 Annual Meeting of Shareholders (Transcript)
Tue, May 7
Baxter International Inc. - Special Call
Tue, May 7
Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease

Business Wire (May 7, 2013)
Baxter Raises Dividend Nine Percent

Business Wire (May 6, 2013)
9 Top Healthcare Dogs Hunt 3.5% To 51.9% Gains In April
Fredrik Arnold • Mon, May 6
Baxter to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Business Wire (Apr 25, 2013)
Renewed Buying Interest In Halozyme After Phase II Initiation
Brian L. Wilson • Wed, Apr 24 • 1 Comment
Baxter to Webcast Annual Meeting of Shareholders

Business Wire (Apr 24, 2013)
Baxter Presents Phase I/II Data Evaluating Lyme Disease Vaccine at NFID Annual Conference on Vaccine Research

Business Wire (Apr 24, 2013)
Enough On Da Vinci: What About Growth?
Nick Chiu • Fri, Apr 19 • 14 Comments
Baxter International Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, Apr 18
Baxter Achieves Its First Quarter Expectations and Confirms 2013 Full-Year Guidance

Business Wire (Apr 18, 2013)

To learn more about Seeking Alpha Pro, click here.

Whisper Number Impact: Earnings Preview For Baxter International
WhisperNumber • Wed, Apr 17
Baxter International: A Solid Healthcare Stock
Ulfberht Capital • Tue, Apr 2 • 1 Comment
Whisper Number Impact: Earnings Preview For Baxter International
WhisperNumber • Wed, Jan 23
Baxter International Inc: Fundamental Stock Research Analysis
F.A.S.T. Graphs • Wed, Jan 16 • 3 Comments
Baxter - Investors Applaud The Excellent Addition Of Gambro
The Value Investor • Wed, Dec 5, 2012 • 2 Comments
Baxter Getting Its Blood Pumping Over Gambro
EP Vantage • Mon, Nov 26, 2012 • 3 Comments
Baxter's Reported Interest To Buy Gambro Fits Well With Its Long-Term Growth Objectives
Chandrasekhar Rajagopalan • Mon, Nov 26, 2012 • 1 Comment
Breaking Barriers In Cardiovascular Treatments
A John Hodge • Mon, Nov 19, 2012 • 2 Comments
Why We Like Baxter's Dividend
Valuentum • Thu, Oct 25, 2012
Is Baxter A Bargain? Management Seems To Think So
Glen S. Woods • Tue, Aug 28, 2012 • 7 Comments
Baxter International: A Dividend Bioscience Company To Consider
David Zanoni • Thu, Aug 23, 2012 • 3 Comments
Baxter: Another High Quality Name For Your Income Portfolio
Paulo Santos • Thu, Jun 21, 2012 • 1 Comment
Baxter Still Defensive, But Is Now The Time For Offense?
Stephen Simpson • Tue, May 15, 2012
Baxter Earnings Preview
Zacks Investment Research • Tue, Apr 17, 2012
Baxter International Inc: Healthy Opportunity At A Low Price With A High Dividend
F.A.S.T. Graphs • Tue, Apr 3, 2012
Baxter's A Buy For Growth, Cash Flow, And Rising Dividends
Ingrid Hendershot • Tue, Mar 13, 2012
Baxter International Inc.: Worth A Look
Intrinsic Valuation • Mon, Mar 12, 2012 • 2 Comments
Waiting For A Dividend Increase At Baxter
Valuentum • Mon, Feb 13, 2012 • 1 Comment
Baxter Worth $65 Given Hospira's Shocking Troubles
Takeover Analyst • Mon, Jan 23, 2012 • 1 Comment
In Search Of Rising Dividends: Baxter International
K202 • Wed, Jan 11, 2012 • 7 Comments

Diversify Into Singapore Dollars And Get 4% Yields With High Quality Baa3 Rated Bonds
Randy Durig • Fri, May 17 • 4 Comments
Ultimate Sustainable Dividend Portfolio - May 2013 Update - Crushing the S&P 500
Intelligent Speculator • Wed, May 15 • 16 Comments
Does Cell Therapy Hold The Key To Treating Stroke?
PropThink • Mon, May 13 • 11 Comments
My K.I.S.S. Portfolio May 2013 Update
The Part-time Investor • Mon, May 13 • 60 Comments
Interviewing Dr. Losordo: The Promising Development Of CD34 Cells
Brian Nichols • Wed, May 8 • 13 Comments
9 Top Healthcare Dogs Hunt 3.5% To 51.9% Gains In April
Fredrik Arnold • Mon, May 6
Renewed Buying Interest In Halozyme After Phase II Initiation
Brian L. Wilson • Wed, Apr 24 • 1 Comment
Enough On Da Vinci: What About Growth?
Nick Chiu • Fri, Apr 19 • 14 Comments
The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy
Brian Nichols • Wed, Apr 10 • 28 Comments
China Biotech In Review: Sanofi In The Hunt For China M&A
ChinaBio Today • Sun, Apr 7
Dividend Challengers Smackdown XXXVII
David Fish • Thu, Apr 4 • 20 Comments
CareFusion On The Right Path
Stephen Simpson • Wed, Apr 3
Dogging The Dow And S&P 500: A First-Quarter Review
Joseph P. Porter • Mon, Apr 1 • 2 Comments
4 Stocks With Rapidly Growing Dividends
Zacks Investment Research • Tue, Mar 26 • 1 Comment
Halozyme Rallies On Success In Europe, US Next Target
Brian L. Wilson • Tue, Mar 26
Last Week's Biotech Movers: Are Any A Buy?
Brian Nichols • Mon, Mar 25 • 16 Comments
Common Sense Says Time For Quality, Dividends And Premiums
George Acs • Sat, Mar 23 • 42 Comments
Top 9 March Healthcare Dogs Mark 3.4% To 28.7% Gains
Fredrik Arnold • Sat, Mar 23 • 2 Comments
2 Large-Cap, 1 Small-Cap Medical Device Stocks To Buy
Takeover Analyst • Fri, Mar 22 • 1 Comment
Cell Therapy Leader Stephen Potter Talks Osiris, NeoStem And The Industry Itself
Brian Nichols • Tue, Mar 19 • 2 Comments

Baxter International's CEO Hosts 2013 Annual Meeting of Shareholders (Transcript)
Tue, May 7
Baxter International Inc. - Special Call
Tue, May 7
Baxter International Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, Apr 18
Baxter International's Management Presents at Citi 2013 Global Healthcare Conference (Transcript)
Mon, Feb 25
Baxter International Management Discusses Q4 2012 Results - Earnings Call Transcript
Thu, Jan 24
Baxter International Management Discusses Q3 2012 Results - Earnings Call Transcript
Thu, Oct 18, 2012
Baxter International Management Discusses Q2 2012 Results - Earnings Call Transcript
Thu, Jul 19, 2012
Baxter International's CEO Hosts 2012 Annual Meeting of Shareholders (Transcript)
Tue, May 8, 2012
Baxter International's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Thu, Apr 19, 2012
Baxter International's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Thu, Jan 26, 2012
Baxter International's CEO Discusses Q3 2011 Results - Earnings Call Transcript
Thu, Oct 20, 2011
Baxter International's CEO Discusses Q2 2011 Results - Earnings Call Transcript
Thu, Jul 21, 2011
Baxter International's CEO Discusses Q1 2011 Results - Earnings Call Transcript
Thu, Apr 21, 2011
Baxter International's CEO Discusses Q4 2010 Results - Earnings Call Transcript
Thu, Jan 27, 2011
Baxter International CEO Discusses Q3 2010 Results - Earnings Call Transcript
Thu, Oct 21, 2010
Baxter International Q2 2010 Earnings Call Transcript
Thu, Jul 22, 2010
Baxter International Inc. Q1 2010 Earnings Call Transcript
Thu, Apr 22, 2010
Baxter International Inc. Q4 2009 Earnings Call Transcript
Thu, Jan 28, 2010
Baxter International Inc. Q3 2009 Earnings Call Transcript
Thu, Oct 15, 2009
Baxter International Inc. Q2 2009 Earnings Call Transcript
Thu, Jul 16, 2009

Baxter to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference

Business Wire (Mon, 9:00AM)
Cramer: Break-Up Could Boost This Stock 19%

at CNBC.com (Fri, 6:02PM)
Health Statistics Pioneer Dorothy P. Rice, Sc.D., Named 2013 Recipient of the William B. Graham Prize for Health Services Research

Business Wire (May 9, 2013)
Midday Movers: P, WFC, C & More

at CNBC.com (May 7, 2013)
Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease

Business Wire (May 7, 2013)
Baxter Raises Dividend Nine Percent

Business Wire (May 6, 2013)
Baxter to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Business Wire (Apr 25, 2013)
Baxter to Webcast Annual Meeting of Shareholders

Business Wire (Apr 24, 2013)
Baxter Presents Phase I/II Data Evaluating Lyme Disease Vaccine at NFID Annual Conference on Vaccine Research

Business Wire (Apr 24, 2013)
Baxter Achieves Its First Quarter Expectations and Confirms 2013 Full-Year Guidance

Business Wire (Apr 18, 2013)
Weekly Jobless Claims Could Be Huge for Markets

at CNBC.com (Apr 17, 2013)
Baxter Marks World Hemophilia Day by Reinforcing Commitment to Addressing Disparities in Care and Sharing New Vision for the Future

Business Wire (Apr 16, 2013)
Weekend Investor: Top forecasters know where to put your money now

at MarketWatch.com (Apr 8, 2013)
Baxter Taps New Technologies, Forms Collaborations to Improve Environmental Sustainability and Access to Healthcare

Business Wire (Apr 2, 2013)
Baxter International First Quarter 2013 Financial Results Conference Call

Business Wire (Mar 27, 2013)
Baxter and Halozyme Announce Positive Opinion for HyQvia for Treatment of Primary and Secondary Immunodeficiencies in the European Union

Business Wire (Mar 22, 2013)
Baxter to Present at Raymond James 34th Annual Institutional Investors Conference

Business Wire (Feb 27, 2013)
Baxter Submits Application for FDA Approval of FEIBA NF for Prophylactic Use in Hemophilia A and B Patients with Inhibitors

Business Wire (Feb 26, 2013)
Baxter Declares Quarterly Dividend

Business Wire (Feb 19, 2013)
Baxter to Present at Upcoming Global Healthcare Conferences

Business Wire (Feb 7, 2013)

BAX vs. ETF Alternatives

Company Description

Baxter develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique... More

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, May 7, 1:54 PM Barclays comes to the defense of Baxter (BAX -3.1%) this afternoon, upping the stock to Overweight on today's weakness. The stock was hit after the drug-maker said Phase III testing of its Gammagard treatment for Alzheimer's disease did not meet its co-primary endpoints. Comment! [Healthcare, On the Move]
Tuesday, May 7, 8:25 AM Baxter International (BAX) slips 2.2% premarket after Phase III testing on its Alzheimer's drug immunoglobulin (IG) - always a long shot - failed to meet its co-primary endpoints. (PR) 1 Comment [Healthcare, On the Move]
Tuesday, May 7, 6:21 AM Baxter International (BAX) declares $0.49/share quarterly dividend, 9% increase from prior dividend of $0.45. Forward yield 2.56%. For shareholders of record June 07. Payable July 01. Ex-div date June 05. (PR) Comment! [Dividends]
Monday, May 6, 7:02 AM Vical (VICL) says the addition of its Vaxfectin adjuvant to Baxter's (BAX) influenza vaccines "substantially increases both antibody and T-cell responses." VICL's VP of vaccine research says seasonal influenza vaccines sometimes underperform in elderly patients — "a good adjuvant could" help, he adds. (PR) Comment! [Healthcare]
Friday, April 26, 3:42 PM Looking for dividend picks, Marketwatch screens the S&P 1,500 for 1) Stock trades at less than a 17x PE 2) Dividend yield 20% or more higher than S&P 500 3) Raised dividend at least 5 times in last 5 years 4) S&P Quality Rank of B+ or better. The winners: T, AVA, BAX, CAH, CAG, ED, JNJ, LG, TAP, RAI, SCG, UVV, WR, XEL. 1 Comment
Thursday, April 18, 9:03 AM More on Baxter (BAX) Q1: net profit -11% to $552M, dragged down by charges related to its purchase of Gambrro, while last year's figures included a tax benefit. Medical-products sales -0.4% to $1.92B, BioScience revenue +4.7% to $1.53B. Expects sales growth of 4% in Q2 and 10% for FY; forecasts EPS of Q2 EPS of $1.12-1.14 vs consensus of $1.14 and 2014 EPS of $4.60-4.70 vs 4.66. (PR) Comment! [Healthcare, Earnings]
Thursday, April 18, 7:03 AM Baxter (BAX): Q1 EPS of $1.05 in-line. Revenue of $3.45B (+2% Y/Y) misses by $0.04B. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, April 18, 12:05 AM Notable earnings before Thursday’s open: ADS, AN, APH, BAX, BBT, BPOP, BTU, BX, CY, DHR, FCS, FCX, FITB, KEY, LDK, MMR, MS, NOK, NUE, OMC, PBCT, PENN, PEP, PM, PPG, SHW, SNA, SON, TSM, TZOO, UNH, UNP, VZ Comment! [Earnings]
Wednesday, April 17, 5:30 PM Notable earnings before Thursday’s open: ADS, AN, APH, BAX, BBT, BPOP, BTU, BX, CY, DHR, FCS, FCX, FITB, KEY, LDK, MMR, MS, NOK, NUE, OMC, PBCT, PENN, PEP, PM, PPG, SHW, SNA, SON, TSM, TZOO, UNH, UNP, VZ Comment! [Earnings]
Thursday, April 4, 4:45 AM The cost of caring for people with dementia is $157-215B a year and could double by 2040, a study from RAND Corp. estimates. The cost of dementia treatment is $109B - above the $102B spent on heart disease and the $77B on cancer - with the other dementia expenses used for long-term day-to-day care. Companies that develop drugs for Alzheimer's disease and other conditions include Pfizer (PFE), Eli Lilly (LLY), J&J (JNJ) and Merck (MRK). 5 Comments [Healthcare]
Friday, March 22, 9:29 AM Halozyme Therapeutics (HALO) +18.6% premarket after the European Medicines Agency approves partner Baxter (BAX) for the use of HALO's HyQvia as replacement therapy for adult patients with primary and secondary immunodeficiencies. Upon receiving marketing authorization from the EC, BAX plans to launch HyQvia in some European countries later this year. Comment! [Healthcare, On the Move]
Tuesday, February 19, 9:35 AM Baxter International Inc. (BAX) declares $0.45/share quarterly dividend, in line with previous. Forward yield 2.64%. For shareholders of record Mar. 08. Payable Apr. 01. Ex-div date Mar. 06. (PR) Comment! [Dividends]
Thursday, January 24, 9:14 AM More on Baxter's (BAX) Q4 results: Forecasts current-quarter EPS of $1.03-$1.05 on 2%-3% sales growth vs. consensus of $1.10 on 4% revenue growth to $3.5B. Forecasts 2013 EPS of $4.60-$4.70 on 10% sales growth vs. consensus $4.84 on 5% revenue growth of $14.8B. Acquires investigational hemophilia compound OBI-1 and related assets from Inspiration BioPharmaceuticals. Comment! [Earnings, Healthcare]
Thursday, January 24, 7:03 AM Baxter (BAX): Q4 EPS of $1.26 in-line. Revenue of $3.8B (+4% Y/Y) beats by $0.08B. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, January 24, 12:05 AM Notable earnings before Thursday’s open: ABC, ALK, ARG, AVT, BAX, BMY, BPOP, CELG, CY, DOV, EQT, ESI, ETN, FCS, GWW, JNS, JVA, KCG, KEY, LMT, LUV, MKC, MMM, MWW, NMM, NOK, ORI, PCP, QSII, RTN, RYN, SWK, TZOO, UAL, UNP, XRX Comment! [Earnings]
Wednesday, January 23, 5:30 PM Notable earnings before Thursday’s open: ABC, ALK, ARG, AVT, BAX, BMY, BPOP, CELG, CY, DOV, EQT, ESI, ETN, FCS, GWW, JNS, JVA, KCG, KEY, LMT, LUV, MKC, MMM, MWW, NMM, NOK, ORI, PCP, QSII, RTN, RYN, SWK, TZOO, UAL, UNP, XRX Comment! [Earnings]

WhisperNumber
Alerts issued this morning for $AXP, $BAX, $FITB, $UNP, and $VZ. http://bit.ly/17e4eoA
Apr 18, 8:55 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

WhisperNumber
$BAX earnings $1.05, seven cents short of the whisper number. Expected price reaction: http://seekingalpha.com/a/swgf
Apr 18, 8:30 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ltfinger
Today's Potential Downgrades (3/18/13): $ACN, $ADBE, $APH, $ATHN, $ATW, $AVGO, $BAX, $BPL, $BRK.B, $BWA, $CAM, $CELG, $CERN
Mar 19, 7:41 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ltfinger
New Upgrades (3/4/2013): $BAX, $CBST, $DVA, $EFX, $HES, $RYN, $THRX, $VRX, $WMT
Mar 4, 10:25 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Eric Cota
Baxter International Inc: $BAX Cash Flow Valuation Update http://goo.gl/9NFsj
9/4/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
3 Profitable Large Cap Dividend Stocks That Analysts Rate A Buy http://bit.ly/PsB3Xa $BAX $BBL $MCD @ZetaKap
8/16/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
7 Profitable Healthcare Stocks That Analysts Love http://bit.ly/RFfOFS $BAX $BIIB $MDT $MNTA $SLXP $THOR $VAR @ZetaKap
8/10/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Randy Lacen
Consumer Discretionary and Healthcare stock mix to play in an upward trending stock-market: MNST, UNFI, TEA, GNC, BAX, PRGO, WMT, WFM
7/30/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Julius Ferraro
Out of BAX and into HAL. I've never had a better 3 days of trading. Doubled my gains for the year in 3 days :)
6/18/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Julius Ferraro
Sold over half my MOS and bought a chunk of BAX. What a boring day today
6/18/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

BAX Baxter International Inc

BAX

Baxter International Inc